🚀 VC round data is live in beta, check it out!

Vitaminka Valuation Multiples

Discover revenue and EBITDA valuation multiples for Vitaminka and similar public comparables like Salada Foods Jamaica, Excellence, Natural Alternatives International, Seko and more.

Vitaminka Overview

About Vitaminka

Vitaminka AD manufactures pasteurized and sterilized products. Its product offerings include marmalades, jams, ajvar, beetroot, cucumber, paprika fillet, mixed salad, pepperoni, fruit juices, nectars and fruit syrups.


Founded

1974

HQ

Bosnia and Herzegovina

Employees

682

Financials (FY)

Revenue: $68M
EBITDA: $6M

EV

$48M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Vitaminka Financials

Vitaminka reported last fiscal year revenue of $68M and EBITDA of $6M.

In the same fiscal year, Vitaminka generated $23M in gross profit, $6M in EBITDA, and $2M in net income.


Vitaminka P&L

In the most recent fiscal year, Vitaminka reported revenue of $68M and EBITDA of $6M.

Vitaminka is profitable as of last fiscal year, with gross margin of 34%, EBITDA margin of 9%, and net margin of 3%.

See analyst estimates for Vitaminka
Last FY20232024202620272028
Revenue$68M$63M$68M
Gross Profit$23M$21M$23M
Gross Margin34%34%34%
EBITDA$6M$6M$6M
EBITDA Margin9%10%9%
EBIT Margin4%5%4%
Net Profit$2M$2M$2M
Net Margin3%3%3%
Net Debt$11M

Financial data powered by Morningstar, Inc.

Vitaminka Stock Performance

Vitaminka has current market cap of $18M, and enterprise value of $48M.

Market Cap Evolution


Vitaminka's stock price is $239.79.

Vitaminka share price increased by 0.5% in the last 30 days, and by 10.6% in the last year.

Vitaminka has an EPS (earnings per share) of $23.25.

See more trading valuation data for Vitaminka
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$48M$18M0.0%0.5%-0.5%10.6%$23.25

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Vitaminka Valuation Multiples

Vitaminka trades at 0.7x EV/Revenue multiple, and 7.8x EV/EBITDA.

See NTM and 2027E valuation multiples for Vitaminka

Vitaminka Financial Valuation Multiples

As of May 3, 2026, Vitaminka has market cap of $18M and EV of $48M.

Vitaminka has a P/E ratio of 10.3x.

Last FY20232024202620272028
EV/Revenue0.7x0.8x0.7x
EV/EBITDA7.8x7.8x7.8x
EV/EBIT15.7x14.7x15.7x
EV/Gross Profit2.1x2.2x2.1x
P/E10.3x9.3x10.3x
EV/FCF(70.1x)15.1x(70.1x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Vitaminka Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Vitaminka Margins & Growth Rates

In the most recent fiscal year, Vitaminka reported gross margin of 34%, EBITDA margin of 9%, and net margin of 3%.

See estimated margins and future growth rates for Vitaminka

Vitaminka Margins

Last FY2024202720282029
Gross Margin34%34%
EBITDA Margin9%9%
EBIT Margin4%4%
Net Margin3%3%
FCF Margin(1%)(1%)

Vitaminka Growth Rates

23/2426/2727/2828/29
Revenue Growth8%
Gross Profit Growth8%
EBITDA Growth1%
EBIT Growth(6%)
Net Profit Growth(9%)
FCF Growth(121%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Vitaminka Operational KPIs

Vitaminka's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.

Access forward-looking KPIs for Vitaminka
Last FY20232024202620272028
Revenue per Employee$0.1M
Opex per Employee$0.0M
S&M Expenses to Revenue3%3%3%
G&A Expenses to Revenue1%1%1%
Opex to Revenue29%29%29%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Salada Foods Jamaica1.5x8.8x
Excellence0.7x4.4x
Natural Alternatives International0.6x(14.2x)
Seko0.3x3.4x
Epsium Enterprise1.3x39.5x
KKO International2.1x6.2x
Industrias Productos Alimenticios0.1x1.6x
Biogena34.7x41.0x

This data is available for Pro users. Sign up to see all Vitaminka competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Vitaminka

When was Vitaminka founded?Vitaminka was founded in 1974.
Where is Vitaminka headquartered?Vitaminka is headquartered in Bosnia and Herzegovina.
How many employees does Vitaminka have?As of today, Vitaminka has over 682 employees.
Is Vitaminka publicly listed?Yes, Vitaminka is a public company listed on Macedonian Stock Exchange.
What is the stock symbol of Vitaminka?Vitaminka trades under VITA ticker.
Who are competitors of Vitaminka?Vitaminka main competitors include Salada Foods Jamaica, Excellence, Natural Alternatives International, Seko, Epsium Enterprise, KKO International, Industrias Productos Alimenticios, Biogena, Fruticola Viconto, Willamette Valley.
What is the current market cap of Vitaminka?Vitaminka's current market cap is $18M.
What is the current revenue of Vitaminka?Vitaminka's last fiscal year revenue is $68M.
What is the current EV/Revenue multiple of Vitaminka?Current revenue multiple of Vitaminka is 0.7x.
Is Vitaminka profitable?No, Vitaminka is not profitable.
How many companies Vitaminka has acquired to date?Vitaminka hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Vitaminka has invested to date?Vitaminka hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Vitaminka

Lists including Vitaminka

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial